Introduction
Noninvasive ventilation (NIV) reduces the need for endotracheal intubation, the occurrence of nosocomial infections, and both morbidity and mortality associated with respiratory failure. [1] [2] [3] [4] [5] The benefits of NIV are greater if started early, thus constituting the rationale for the increasing use of NIV in prehospital and emergency department settings. [6] [7] [8] Because of its ease of use and the small size of commercially available devices, CPAP is the most commonly used NIV technique in these settings. 5, 9 The benefits of CPAP have been extensively described in the treatment of acute cardiogenic pulmonary edema [10] [11] [12] and acute respiratory failure [13] [14] [15] and include opening collapsed alveoli, preserving patency of already open-lung units, improving gas exchange, reducing patient's work of breathing, 16 and increasing cardiac performance by a reduction in venous return and left-ventricular afterload. [17] [18] [19] CPAP can be delivered with masks or helmets.
For successful CPAP treatment, CPAP devices must deliver sufficiently high air flow to maintain airway pressure throughout the breathing cycle. Because conditions such as tachypnea, high minute ventilation, or large tidal volumes can increase inspiratory flows, air flow delivered by CPAP devices should always be higher than the patient's peak inspiratory flow to ensure positive airway pressure during the entire breathing cycle. A minimum of 60 L/min is generally considered sufficient to guarantee a constant CPAP level under most degrees of patient inspiratory demand, 20 although higher flows might be required in severe respiratory distress at high breathing frequency, large tidal volumes, and high minute ventilation. 20, 21 Delivered F IO 2 is dependent upon the amount of air entrained during the operation of the device and the patient's inspiratory demand. If the device entrains a large volume of room air, the maximum F IO 2 will be limited. In addition, the more that the patient's inspiratory demand exceeds the total air-flow output of the device, the lower the F IO 2 will be because additional room air must be entrained to meet the patient's demand for inspiratory flow.
The aim of this study was to evaluate and compare the intrinsic capabilities of 5 commercially available CPAP devices in prehospital and emergency settings. The performance of each device was evaluated in terms of effectiveness (air-flow output, pressure, and F IO 2 ) and efficiency (oxygen consumption by the device).
Methods

Devices
Five commercially available devices for delivery of noninvasive CPAP in prehospital settings were studied ( Fig.  1 The Ventumask, EasyVent, Ventukit, and EVE Coulisse devices use the Venturi effect to entrain room air and generate a high gas output flow and an adjustable mechanical CPAP valve to set the desired positive pressure. A supplementary oxygen source located downstream from the air-entrainment valve can be connected to increase F IO 2 . Tables provided by the manufacturers indicate, for each level of CPAP, the oxygen flows needed to provide a specific total air flow and F IO 2 with a maximum use of 15 L/min oxygen.
The Boussignac CPAP system uses the virtual Boussignac valve, consisting of a small cylinder with 4 microchannels: when receiving oxygen flow from a source, turbulence is generated inside the cylinder itself, resulting in a positive pressure. The performance of the Boussignac CPAP system depends only on the delivered oxygen flow: F IO 2 and positive pressure cannot be set by the operator because both are a result of the oxygen flow setting required to power the device and the amount of air the patient inhales above that delivered by the device. This device does not incorporate an air-entrainment Venturi system.
The Ventukit and EVE Coulisse are 2 transparent, latexfree, polyvinylchloride hoods joined by a metal ring to soft polyvinylchloride collars to form helmets. These devices have an internal gas volume of 17 L. Both helmets include an air-entrainment system utilizing the Venturi effect and an adjustable CPAP valve. The Ventukit helmet has a plug to reduce the noise generated by the device at the exit point of the flow generated by the air-entrainment Venturi system exerting 6 cm H 2 O per 50 L/min resistance to gas flow.
QUICK LOOK
Current knowledge
CPAP is frequently used in prehospital and emergency settings. A minimum flow output of 60 L/min and a constant positive pressure are 2 important features of a successful CPAP device. CPAP devices for ambulances typically need only an oxygen source to function. Inspired oxygen can be altered by air entrainment, which also increases total flow. Prehospital use of CPAP for cardiogenic pulmonary edema is associated with improved clinical outcomes.
What this paper contributes to our knowledge
In a bench study of 5 CPAP devices, there were considerable differences in performance among the devices tested. The EasyVent and EVE Coulisse achieved the best overall performance in terms of effectiveness and efficiency; the Ventumask and Ventukit presented more limited air-flow outputs at lower positive pressures; and the Boussignac CPAP system delivered low total airflow outputs, low positive pressures, and high nonadjustable F IO 2 . Clinicians and prehospital caregivers should be aware of specific device performance characteristics to optimize effective application of CPAP in prehospital and emergency settings.
Comparisons were performed between masks and between helmets because the devices from the same manufacturer (Ventumask/Ventukit and EasyVent/EVE Coulisse) use the same air-entrainment system and the difference between devices is the interfaces (mask or helmets). Moreover, the choice to use a mask or a helmet is strictly clinical, based on the patient's adherence or expected duration of needed assistance. Figure 2 shows the in vitro circuit used to evaluate the performance of each device in terms of flow, generated pressure, and delivered F IO 2 . A flow meter (ICU-Lab, KleisTEK, Bari, Italy) measuring air flow generated by the CPAP device was positioned downstream from each CPAP device's air-entrainment valve, as well as a rapid-response oxygen analyzer (MaxO 2 ϩ AE, Maxtec, Salt Lake City, Utah) and a manometer.
Experimental Setting
The Ventumask, EasyVent, Ventukit, and EVE Coulisse devices were evaluated without CPAP and at 4 levels of CPAP (5, 10, 15, and 20 cm H 2 O) set with each device's adjustable valve. For each CPAP valve level, the devices were tested at oxygen source flows of 5-15 L/min in 1 L/min increments, and generated pressure, air flow, and F IO 2 were measured. The Boussignac CPAP system was evaluated for delivered air flow, F IO 2 , and pressure starting at 5 L/min oxygen up to 30 L/min, as recommended by the manufacturer, in 1 L/min increments from 5 to 15 L/min and then in 5 L/min steps to 30 L/min.
Each device was evaluated during simulated spontaneous breathing using a lung model. Airway pressure stability throughout the breathing cycle, estimated by calculating the mean of the pressure excursion inside the device chamber (maximum pressure-minimum pressureϭexcursion pressure), was used as an indirect index of work of breathing. As shown in Figure 2 , a pneumatic lung simulator (Dimar) generating a mildly tachypneic sinusoidal flow pattern (tidal volume 500 mL, inspiratory time 0.8 s, expiratory time 1.6 s, breathing frequency 25 breaths/min) was directly connected to each device. A pneumotachograph and pressure transducer (ICULab) were positioned between devices and the pneumatic lung simulator, and each device was tested during 60 s of uninterrupted simulated breathing. Air-entrainment devices were evaluated by delivering increasing levels of oxygen flow from 5 to 15 L/min in 1 L/min increments and then from 15 to 30 L/min in 5 L/min increments and at 4 different CPAP levels (5, 10, 15, and 20 cm H 2 O), set with each device's adjustable CPAP valve. The Boussignac CPAP system was tested by delivering an increasing flow of oxygen from 5 to 30 L/min. For all devices, pressure excursion was calculated as mean of the pressure excursion over the 25 ventilatory cycles occurring during the recording time.
In addition, device oxygen consumption or rather oxygen inflow requirement was calculated from an oxygen tank (volume of 7 L) fully charged at 200 bar for a total 1,400 L of oxygen. The oxygen flow needed to generate a minimum air-flow output of 60 L/min was used to estimate efficiency in total minutes of run time. All experiments were carried out by the same researcher (CB).
Statistical Analysis
Data are expressed as mean Ϯ SD. All statistical analyses were performed using SPSS 21 (IBM, Armonk, New York), and significance was considered to be P Ͻ .05. All data were analyzed by averaging measurements on 3 different devices of each evaluated model.
Gas Output Flow Generation Performances
The total gas output flow obtainable with the different devices was compared by 2-way analysis of variance, with input flow and device as factors. The relationship between oxygen input flow and generated air-flow outputs of each device was tested by linear regression analysis. 
Static Test
Masks and helmets were analyzed separately. The generated flows and F IO 2 of devices, at a fixed oxygen input flow of 15 L/min, were compared by 2-way analysis of variance, with CPAP level and device as factors. Differences between devices at a given CPAP level were tested post hoc, and P values of multiple comparisons were corrected using the Bonferroni correction.
Dynamic Test
Masks and helmets were analyzed separately. Normality of distributions was assessed by the D'Agostino-Pearson omnibus test, and correlations were assessed by Pearson R or Spearman's rho, accordingly. Pressure excursions of masks and helmets were compared by 2-way analysis of variance, with CPAP level and device as factors. Differences between devices at a given CPAP level were tested post hoc, and P values of multiple comparisons were corrected using the Bonferroni correction.
Results
Gas Output Flow Generation Performances
The gas output flow of each device without a CPAP valve was linearly related to the oxygen input flow (Fig.  3) , and the results of linear regression are reported in Table  1 . The EasyVent (83 Ϯ 27 L/min) and EVE Coulisse (78 Ϯ 28 L/min) produced a greater air-flow output than the Ventumask (49 Ϯ 20 L/min), Boussignac CPAP system (10 Ϯ 4 L/min), and Ventukit (45 Ϯ 10 L/min) at all oxygen input flows (P Ͻ .001 for comparisons between all pairs of devices, except EasyVent vs EVE Coulisse at an input flow of 14 L/min, P Ͼ .99). 
Static Test
Masks. Considering the architectural differences between the Boussignac CPAP system and the other 4 devices (in particular, the inability to preset a positive pressure and F IO 2 ), an initial separate characterization was performed (Fig. 4) . The maximum positive pressure achieved with the Boussignac CPAP system was 9 cm H 2 O at an oxygen input flow of 30 L/min; therefore, no direct comparison with other mask devices could be performed at CPAP levels of 10, 15, and 20 cm H 2 O.
At a CPAP of 5 cm H 2 O, the EasyVent generated a higher output flow than the Ventumask and Boussignac (120, 75, and 15 L/min, respectively; P Ͻ .001 for all pairwise comparisons), with a lower F IO 2 (31, 37, and 58%, P Ͻ .001 for all comparisons). At a CPAP of 10 cm H 2 O, the EasyVent generated a higher output flow than the Ventumask (118 vs 70 L/min, P Ͻ .001), with a lower F IO 2 (30% vs 40%, P Ͻ .001). At a CPAP of 15 cm H 2 O, the EasyVent generated a higher output flow than Ventumask (100 vs 72 L/min, P Ͻ .001), with a lower F IO 2 (33% vs 42%, P Ͻ .001). At a CPAP of 20 cm H 2 O, the EasyVent generated a higher output flow than the Ventumask (90 vs 40 L/min, P Ͻ .001), with a lower F IO 2 (35% vs 55%, P Ͻ .001).
Helmets. At a CPAP of 5 cm H 2 O, the EVE Coulisse generated a higher output flow than the Ventukit (120 vs 60 L/min, P Ͻ .001), with a lower F IO 2 (31% vs 41%, P Ͻ .001). At a CPAP of 10 cm H 2 O, the EVE Coulisse generated a higher output flow than the Ventukit (112 vs 46 L/min, P Ͻ .001), with a lower F IO 2 (30% vs 47%, P Ͻ .001). At a CPAP of 15 cm H 2 O, the EVE Coulisse generated a higher output flow than the Ventukit (95 vs 35 L/min, P Ͻ .001), with a lower F IO 2 (32% vs 54%, P Ͻ .001). At a CPAP of 20 cm H 2 O, the EVE Coulisse generated a higher output flow than the Ventukit (80 vs 20 L/min, P Ͻ .001), with a lower F IO 2 (34% vs 80%, P Ͻ .001).
A comparison of the overall efficiency of all devices with the static test is illustrated in Figures 4 and 5 . All CPAP devices showed a reduction of air-flow output and an increase in F IO 2 as the CPAP level was increased.
Dynamic Test
Because the Boussignac CPAP system never reached a minimum air-flow output of 60 L/min, it was considered not to be comparable with the other devices and was not included in the dynamic bench test. Normality assumption for pressure excursion distribution was rejected for both masks and helmets, with P Ͻ .001. The dynamic bench test showed a significant negative correlation between the gas flow generated by the CPAP devices and the pressure excursion inside the device for both masks (rho ϭ Ϫ0.86, P ϭ .01) and helmets (rho ϭ Ϫ0.79, P ϭ .03). For both air-entrainment masks and helmets, a steep decrease in pressure excursion was observed when the delivered flow reached the threshold of 60 L/min (Fig. 6) . Absolute values of pressure excursion were lower in helmets due to their high internal volume.
The EasyVent had significantly lower pressure excursion than the Ventumask at all CPAP levels (P Ͻ .001), and the EVE Coulisse had lower pressure excursion than the Ventukit at 5 cm H 2 O (P Ͻ .001), 15 cm H 2 O (P ϭ .02), and 20 cm H 2 O (P Ͻ .001), whereas at 10 cm H 2 O, no significant difference was observed between the 2 devices (P Ͼ .99). The results of the dynamic test are illustrated in Figure 7 . The efficiency of devices in terms of oxygen consumption needed to achieve the output flow threshold of 60 L/min at a given CPAP level are reported in Table 2 .
Discussion
The major findings of this study are: (1) different devices for noninvasive CPAP varied significantly in their Results of linear regression of output flow versus input flow are reported. ability to deliver high air flow and F IO 2 and to minimize pressure excursion. (2) The Boussignac CPAP system delivered lower total air flows and higher F IO 2 than air-entrainment devices, with pressure and F IO 2 not independently adjustable. (3) Of the air-entrainment devices, the EasyVent and EVE Coulisse were both more effective and efficient than Ventumask and Ventukit. In this study, 5 CPAP devices commercially available for prehospital and emergency department use were evaluated: 3 facial masks and 2 helmets. All of these devices are easily usable during ambulance transport because none require electrical power, but only an oxygen source, making them ideal devices for prehospital emergency settings. Four of these devices use the jet air-entrainment principle to entrain room air, increasing the total air flow delivered to the patient, and adjustable CPAP valves to provide CPAP. The Boussignac CPAP system does not entrain ambient air: the virtual Boussignac valve is designed only to establish a positive pressure.
Over the past decade, the Boussignac CPAP system has been used frequently in emergency settings because it is extremely easy to apply and does not require presettings by the operator other than oxygen flow, making it convenient for use by paramedical personnel on ambulances. [22] [23] [24] We presume that the success of the Boussignac CPAP system is a result of these characteristics and the fact that it delivers a high F IO 2 . However, it does not maintain sufficient air flow to prevent entrainment of ambient air by the patient, affecting both the effective positive pressure applied and F IO 2 delivered. The positive pressure generated by the virtual valve reached a maximum of 9 cm H 2 O when driven by 30 L/min oxygen. Because the virtual valve is in open communication with the external environment, the oxygen concentration is lowered by dilution by ambient air inspiration, and a drop in airway pressure at high minute ventilation has been observed. 25 Moreover, with each breath, depending on the patient's respiratory pattern and strength, a negative pressure will be generated during inspiration, and a reversal of flow through the virtual valve will occur during expiration, thus altering the positive pressure generated by the system and therefore not establishing CPAP.
Of the mask-based devices, the EasyVent demonstrated greater efficiency than the Ventumask at the same CPAP and oxygen settings and generated greater air-flow outputs and lower F IO 2 . The EasyVent generated high air-flow output even with a CPAP of 20 cm H 2 O, always remaining Ն60 L/min. Moreover, 6 L/min oxygen was sufficient to generate an air-flow output of 60 L/min without CPAP but maintained a very low F IO 2 . The Ventumask generated good air-flow outputs at a CPAP of 5-15 cm H 2 O, but total air-flow output decreased to 25 L/min at a CPAP of 20 cm H 2 O, with a consequent increase in F IO 2 (50%). Moreover, 10 L/min oxygen was needed to generate a total air-flow output of 60 L/min at zero CPAP. The differences between these 2 devices in air-flow output may be due to the technical construction of the 2 jet entrainment systems. In fact, with the EasyVent, oxygen flow enters the system in parallel with air flow entrained from the external environment, generating laminar air flow, whereas with the Ventumask, oxygen flow enters at an acute angle to the ambient air flow and entrains less air, possibly due to the generation of turbulence.
Of the helmet devices, the EasyVent and EVE Coulisse were similar in effectiveness, and this result was expected because they both incorporate the same jet entrainment systems applied to 2 different interfaces (mask vs helmet). The Ventukit incorporates the same jet entrainment system as the Ventumask, but the total air-flow output differed between these 2 devices. Inside the helmet at the air-flow output point, the Ventukit includes a plug to reduce the noise generated by the jet entrainment system. This plug certainly reduces the noise inside the helmet, but adds a resistance, measured by the authors as 6 cm H 2 O per 50 L/min, significantly reducing the effectiveness of air entrainment. Unfortunately, this reduction in air entrainment limits the use of the Ventukit because the air-flow output was Ͼ60 L/min only at a CPAP of 5 cm H 2 O, with an oxygen consumption of 14 L/min. An air-flow output Ͼ60 L/min is important in helmets not only to reduce the patient's work of breathing, as with masks, but also to avoid CO 2 rebreathing. 26, 27 The EVE Coulisse maintained a total air-flow output well over 60 L/min with CPAP set from 5 to 20 cm H 2 O and consumed from only 8 L/min oxygen at a CPAP of 5 cm H 2 O to 13 L/min oxygen at a CPAP of 20 cm H 2 O.
Our data also support the clinical relevance of an airflow threshold of 60 L/min, which is recommended in CPAP guidelines. 20, 21 We found increased pressure excursion and negative pressure spikes during the inspiratory phase whenever 60 L/min was not reached (see Fig. 6 ). Comparisons between devices systematically showed significantly larger pressure excursion for those devices that did not reach the 60 L/min threshold. In helmets, low total air flow also resulted in lower pressures during the inspira- tory phase, although pressure remained positive because of the buffering effect of the high internal capacitance of the helmet. Nevertheless, a minimum air-flow output of 60 L/min when applying CPAP through helmets is necessary to avoid the risk of CO 2 rebreathing due to a low washout flow, in addition to minimizing work of breathing.
The effectiveness of CPAP via mask or helmet at identical air flow and pressure is comparable. 28 The choice of device depends on other factors, such as operator experience, device availability, expected time of support, and patient's tolerance. Normally, the mask is more readily available and easier to apply, thus making it suitable for ambulance transport. In the emergency department or the wards, however, the helmet allows greater patient comfort and avoids risk of skin lesions. Despite these general considerations, the use of helmets in prehospital settings is feasible, efficient, and safe. 5, 7 The efficiency of CPAP devices is an important topic especially during prehospital use. In fact, in some countries, oxygen availability on ambulances is limited, and transportation times can vary greatly. Furthermore, oxygen sources in ambulances in some countries can generally deliver only up to a maximum of 15 L/min. Therefore, when higher oxygen flows are needed, as with the Boussignac CPAP system, it is necessary to use 2 tanks simultaneously to achieve a gas delivery of 30 L/min.
The use of prehospital CPAP has increased considerably in recent years due to the growing evidence regarding the importance of early treatment of pathologies such as acute cardiogenic pulmonary edema 5, 6 and acute hypercapnic respiratory failure. 6, 9, 29 However, the most recent studies offer little agreement about the utility of CPAP in improving a patient's outcome. [30] [31] [32] This is, in our opinion, due to the heterogeneity of the approaches used to provide CPAP: many did not specify which CPAP device was used, 9, 33 or they used the Boussignac CPAP system. 23, 24, 34, 35 In contrast, the studies using air-entrainment CPAP systems concluded that CPAP in prehospital setting is highly effective. 8, 36, 37 Due to the variable performance highlighted by this bench study, it is clear that results of clinical trials may be at least partially dependent on the effectiveness of the device used.
Our study has some limitations that need to be addressed. First, the devices were tested only in an in vitro circuit. As a result, we were able to accurately describe and compare the effectiveness and efficiency of each device, but we were not able to reproduce different clinical conditions. Thus, our results cannot be directly extrapolated to the clinical scenario, and larger studies on healthy volunteers and subjects with various respiratory conditions are needed. Second, the devices tested were all CPAP devices for ambulance and emergency settings and are commercially available in Europe. Some new CPAP devices with similar characteristics have recently been developed in the United States. Owing to the heterogeneity of our results obtained with the devices tested in this study, it would be advisable to test with similar methodology the new CPAP devices in the United States but not yet available in Europe.
Conclusions
In summary, we found considerable differences in performance among the 5 CPAP devices tested. The EasyVent and EVE Coulisse achieved the best overall performance in terms of effectiveness and efficiency; the Ventumask and Ventukit presented more limited air-flow outputs at lower positive pressures; and the Boussignac CPAP system delivered low total air-flow outputs, low positive pressures, and high non-adjustable F IO 2 . Clinicians and prehospital caregivers should be aware of specific device performance characteristics to optimize effective application of CPAP in prehospital and emergency settings. The Boussignac CPAP system was not included in this table because its CPAP level cannot be adjusted a priori, and it does not entrain room air. NA ϭ not applicable
